Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sayeh Jalali"'
Autor:
Sayeh Jalali, Negar Zareshahi, Amir Hossein Behnoush, Alireza Azarboo, Amirhossein Shirinezhad, Seyyed Yasin Hosseini, Amin Javidan, Amirhossein Ghaseminejad-Raeini
Publikováno v:
Reproductive Biology and Endocrinology, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Erectile dysfunction (ED) has been linked to insulin resistance (IR), with various surrogate indices being used to assess this association. This systematic review and meta-analysis aimed to evaluate the relationship between IR ind
Externí odkaz:
https://doaj.org/article/6aca9bda070f4fc48ef8e83c5ea13a0e
Autor:
Samrin Farouk Idris Habbani, Sayeh Jalali Dowlatshahi, Monisha Elumalai, Scott Charles Bolton, Lucy Teberh Tecle, Pankti Rajesh Thakkar, Jacqueline C Linnes, Sulma I Mohammed
Publikováno v:
Cancer Research. 83:6531-6531
Cervical cancer is a lethal gynecological malignancy and the fourth most common cancer among women. Most high-grade cervical pre-cancers and cancer cases are linked to infection with high-risk human papillomaviruses (HPV). There is an inequity betwee
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andreas Bakker, Steven G. Deeks, Matthew T. Downs, Kristen Hege, David T. Scadden, Rukmini Pennathur-Das, Ronald T. Mitsuyasu, Margo R. Roberts, Peter A. Anton, Sayeh Jalali, Carl H. June, Andy Lin, Elizabeth Connick
Publikováno v:
Blood. 96:785-793
We have genetically engineered CD4+ and CD8+ T cells with human immunodeficiency virus (HIV) specificity by inserting a gene, CD4ζ, containing the extracellular domain of human CD4 (which binds HIV env) linked to the zeta (ζ) chain of the T-cell re
Autor:
Kay Limoli, Sridhar Reddy, Rukmini Pennathur-Das, Mitchell H. Finer, Deborah Farson, Ryan Mcguinness, Tom Dull, David F. Broad, Sayeh Jalali, Richard Lazar
Publikováno v:
The Journal of Gene Medicine. 1:195-209
Background The use of gene modified T lymphocytes for immunotherapy in a cancer or AIDS clinical trial requires an efficient, safe ex vivo method for modification of these cells at manufacturing scale. Since retroviruses have been shown to be a moder
Autor:
Steven G. Deeks, Richard Lazar, David T. Scadden, Catherine A. Macken, Ronald T. Mitsuyasu, Kristen Hege, Christine Huang, Sayeh Jalali, Douglas D. Richman, Carl H. June, Peter A. Anton, Cindy Christopherson, Bridget Wagner, David F. Broad
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 5(6)
Highly active antiretroviral therapy (HAART) can suppress HIV replication to undetectable levels in plasma, but it is unlikely to eradicate cellular reservoirs of virus. Immunotherapies that are cytolytic may be useful adjuncts to drug therapies that